Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of the trial is to assess the efficacy of Durvalumab and Tremelimumab in comparison to doxorubicin in treatment-naïve Soft tissue sarcoma patients
Epistemonikos ID: b2f06f30bf36dc4a5c47aebf0223b261c0623a25
First added on: May 21, 2024